Humanized anti-OX40 antibodies and uses thereof

摘要

The invention provides humanized anti-0X40 (CD134, TNFRSF4) antibodies. Also provided are methods of making such antibodies, and methods of use, e.g., in T cell activation and the treatment of diseases, such as cancer.